 | • レポートコード：MRC2312MG15499 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の薬物動態試験サービス市場規模と予測を収録しています。・世界の薬物動態試験サービス市場：売上、2018年-2023年、2024年-2029年 ・世界の薬物動態試験サービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の薬物動態試験サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「マイクロスケール熱泳動」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 薬物動態試験サービスのグローバル主要企業は、Proteomics International、 Labcorp、 Pharmaron、 Svar、 NorthEast BioLab、 BioAgilytix、 Washington Biotechnology, Inc.（WBI）、 Eurofins BioPharma、 Charles River、 SCAS、 Chimera、 Phoenix WinNonlin、 CD bioparticles、 ACM Global Laboratories、 WuXi AppTec、 BioGenes、 Pacific BioLabs、 XenoTech、 Medpace、 SGS、 CellCarta、 Precisionなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、薬物動態試験サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の薬物動態試験サービス市場：タイプ別、2018年-2023年、2024年-2029年 世界の薬物動態試験サービス市場：タイプ別市場シェア、2022年 ・マイクロスケール熱泳動、質量分析 世界の薬物動態試験サービス市場：用途別、2018年-2023年、2024年-2029年 世界の薬物動態試験サービス市場：用途別市場シェア、2022年 ・医薬品開発、臨床試験、獣医学、その他 世界の薬物動態試験サービス市場：地域・国別、2018年-2023年、2024年-2029年 世界の薬物動態試験サービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における薬物動態試験サービスのグローバル売上、2018年-2023年 ・主要企業における薬物動態試験サービスのグローバル売上シェア、2022年 ・主要企業における薬物動態試験サービスのグローバル販売量、2018年-2023年 ・主要企業における薬物動態試験サービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Proteomics International、 Labcorp、 Pharmaron、 Svar、 NorthEast BioLab、 BioAgilytix、 Washington Biotechnology, Inc.（WBI）、 Eurofins BioPharma、 Charles River、 SCAS、 Chimera、 Phoenix WinNonlin、 CD bioparticles、 ACM Global Laboratories、 WuXi AppTec、 BioGenes、 Pacific BioLabs、 XenoTech、 Medpace、 SGS、 CellCarta、 Precision ************************************************************* ・調査・分析レポートの概要 薬物動態試験サービス市場の定義 市場セグメント 世界の薬物動態試験サービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の薬物動態試験サービス市場規模 世界の薬物動態試験サービス市場規模：2022年 VS 2029年 世界の薬物動態試験サービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの薬物動態試験サービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の薬物動態試験サービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：マイクロスケール熱泳動、質量分析 薬物動態試験サービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：医薬品開発、臨床試験、獣医学、その他 薬物動態試験サービスの用途別グローバル売上・予測 ・地域別市場分析 地域別薬物動態試験サービス市場規模 2022年と2029年 地域別薬物動態試験サービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Proteomics International、 Labcorp、 Pharmaron、 Svar、 NorthEast BioLab、 BioAgilytix、 Washington Biotechnology, Inc.（WBI）、 Eurofins BioPharma、 Charles River、 SCAS、 Chimera、 Phoenix WinNonlin、 CD bioparticles、 ACM Global Laboratories、 WuXi AppTec、 BioGenes、 Pacific BioLabs、 XenoTech、 Medpace、 SGS、 CellCarta、 Precision ... |
This research report provides a comprehensive analysis of the Pharmacokinetics Testing Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pharmacokinetics Testing Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pharmacokinetics Testing Service, challenges faced by the industry, and potential opportunities for market players.
The global Pharmacokinetics Testing Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pharmacokinetics Testing Service market presents opportunities for various stakeholders, including Drug Development, Clinical Trials. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pharmacokinetics Testing Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pharmacokinetics Testing Service market was valued at US$ 308.4 million in 2022 and is projected to reach US$ 516.4 million by 2029, at a CAGR of 7.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The pharmacokinetics testing service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and advancements in drug development and clinical trials.North America is expected to dominate the pharmacokinetics testing service market due to the presence of a well-established healthcare infrastructure, increasing R&D activities, and a large number of pharmaceutical companies in the region.Europe is also a significant market for pharmacokinetics testing services, driven by the presence of major pharmaceutical companies, increasing investments in drug development, and favorable government initiatives.The Asia Pacific region is expected to witness rapid growth in the pharmacokinetics testing service market due to the increasing outsourcing of drug development activities to countries like India and China, rising healthcare expenditure, and a large patient pool.The pharmacokinetics testing service market is highly fragmented, with the presence of numerous small and large players. However, a few major players dominate the market, accounting for a significant market share. These players have a strong presence in multiple regions and offer a wide range of pharmacokinetics testing services.The increasing focus on personalized medicine and targeted therapies presents significant opportunities for pharmacokinetics testing service providers. Personalized medicine requires precise pharmacokinetic data to determine the optimal drug dosage for individual patients.Technological advancements, such as the development of advanced analytical techniques and high-throughput screening methods, are expected to create new opportunities in the pharmacokinetics testing service market. These advancements enable faster and more accurate analysis of drug metabolism and pharmacokinetic parameters.The pharmacokinetics testing service market is subject to strict regulatory requirements, which can pose challenges for service providers. Compliance with regulatory guidelines and obtaining necessary approvals can be time-consuming and costly. Pharmacokinetics testing services can be expensive, especially for small and medium-sized pharmaceutical companies. The high cost of testing services can act as a barrier to market entry for some players and limit the adoption of these services.Overall, the pharmacokinetics testing service market is expected to grow significantly in the coming years, driven by factors such as the increasing demand for personalized medicine and advancements in drug development. However, challenges such as stringent regulatory requirements and high testing costs need to be addressed for the market to reach its full potential.
Key Features:
The research report on the Pharmacokinetics Testing Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pharmacokinetics Testing Service market.
Market Overview: The report provides a comprehensive overview of the Pharmacokinetics Testing Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Microscale Thermophoresis, Mass Spectrometry), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pharmacokinetics Testing Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pharmacokinetics Testing Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pharmacokinetics Testing Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pharmacokinetics Testing Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pharmacokinetics Testing Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pharmacokinetics Testing Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pharmacokinetics Testing Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pharmacokinetics Testing Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pharmacokinetics Testing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Microscale Thermophoresis
Mass Spectrometry
Market segment by Application
Drug Development
Clinical Trials
Veterinary Medicine
Other
Global Pharmacokinetics Testing Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Proteomics International
Labcorp
Pharmaron
Svar
NorthEast BioLab
BioAgilytix
Washington Biotechnology, Inc.（WBI）
Eurofins BioPharma
Charles River
SCAS
Chimera
Phoenix WinNonlin
CD bioparticles
ACM Global Laboratories
WuXi AppTec
BioGenes
Pacific BioLabs
XenoTech
Medpace
SGS
CellCarta
Precision
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmacokinetics Testing Service, market overview.
Chapter 2: Global Pharmacokinetics Testing Service market size in revenue.
Chapter 3: Detailed analysis of Pharmacokinetics Testing Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacokinetics Testing Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pharmacokinetics Testing Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacokinetics Testing Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacokinetics Testing Service Overall Market Size
2.1 Global Pharmacokinetics Testing Service Market Size: 2022 VS 2029
2.2 Global Pharmacokinetics Testing Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacokinetics Testing Service Players in Global Market
3.2 Top Global Pharmacokinetics Testing Service Companies Ranked by Revenue
3.3 Global Pharmacokinetics Testing Service Revenue by Companies
3.4 Top 3 and Top 5 Pharmacokinetics Testing Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmacokinetics Testing Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacokinetics Testing Service Players in Global Market
3.6.1 List of Global Tier 1 Pharmacokinetics Testing Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacokinetics Testing Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharmacokinetics Testing Service Market Size Markets, 2022 & 2029
4.1.2 Microscale Thermophoresis
4.1.3 Mass Spectrometry
4.2 By Type – Global Pharmacokinetics Testing Service Revenue & Forecasts
4.2.1 By Type – Global Pharmacokinetics Testing Service Revenue, 2018-2023
4.2.2 By Type – Global Pharmacokinetics Testing Service Revenue, 2024-2029
4.2.3 By Type – Global Pharmacokinetics Testing Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmacokinetics Testing Service Market Size, 2022 & 2029
5.1.2 Drug Development
5.1.3 Clinical Trials
5.1.4 Veterinary Medicine
5.1.5 Other
5.2 By Application – Global Pharmacokinetics Testing Service Revenue & Forecasts
5.2.1 By Application – Global Pharmacokinetics Testing Service Revenue, 2018-2023
5.2.2 By Application – Global Pharmacokinetics Testing Service Revenue, 2024-2029
5.2.3 By Application – Global Pharmacokinetics Testing Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Pharmacokinetics Testing Service Market Size, 2022 & 2029
6.2 By Region – Global Pharmacokinetics Testing Service Revenue & Forecasts
6.2.1 By Region – Global Pharmacokinetics Testing Service Revenue, 2018-2023
6.2.2 By Region – Global Pharmacokinetics Testing Service Revenue, 2024-2029
6.2.3 By Region – Global Pharmacokinetics Testing Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Pharmacokinetics Testing Service Revenue, 2018-2029
6.3.2 US Pharmacokinetics Testing Service Market Size, 2018-2029
6.3.3 Canada Pharmacokinetics Testing Service Market Size, 2018-2029
6.3.4 Mexico Pharmacokinetics Testing Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Pharmacokinetics Testing Service Revenue, 2018-2029
6.4.2 Germany Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.3 France Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.4 U.K. Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.5 Italy Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.6 Russia Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.7 Nordic Countries Pharmacokinetics Testing Service Market Size, 2018-2029
6.4.8 Benelux Pharmacokinetics Testing Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Pharmacokinetics Testing Service Revenue, 2018-2029
6.5.2 China Pharmacokinetics Testing Service Market Size, 2018-2029
6.5.3 Japan Pharmacokinetics Testing Service Market Size, 2018-2029
6.5.4 South Korea Pharmacokinetics Testing Service Market Size, 2018-2029
6.5.5 Southeast Asia Pharmacokinetics Testing Service Market Size, 2018-2029
6.5.6 India Pharmacokinetics Testing Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Pharmacokinetics Testing Service Revenue, 2018-2029
6.6.2 Brazil Pharmacokinetics Testing Service Market Size, 2018-2029
6.6.3 Argentina Pharmacokinetics Testing Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pharmacokinetics Testing Service Revenue, 2018-2029
6.7.2 Turkey Pharmacokinetics Testing Service Market Size, 2018-2029
6.7.3 Israel Pharmacokinetics Testing Service Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmacokinetics Testing Service Market Size, 2018-2029
6.7.5 UAE Pharmacokinetics Testing Service Market Size, 2018-2029
7 Pharmacokinetics Testing Service Companies Profiles
7.1 Proteomics International
7.1.1 Proteomics International Company Summary
7.1.2 Proteomics International Business Overview
7.1.3 Proteomics International Pharmacokinetics Testing Service Major Product Offerings
7.1.4 Proteomics International Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.1.5 Proteomics International Key News & Latest Developments
7.2 Labcorp
7.2.1 Labcorp Company Summary
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Pharmacokinetics Testing Service Major Product Offerings
7.2.4 Labcorp Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.2.5 Labcorp Key News & Latest Developments
7.3 Pharmaron
7.3.1 Pharmaron Company Summary
7.3.2 Pharmaron Business Overview
7.3.3 Pharmaron Pharmacokinetics Testing Service Major Product Offerings
7.3.4 Pharmaron Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.3.5 Pharmaron Key News & Latest Developments
7.4 Svar
7.4.1 Svar Company Summary
7.4.2 Svar Business Overview
7.4.3 Svar Pharmacokinetics Testing Service Major Product Offerings
7.4.4 Svar Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.4.5 Svar Key News & Latest Developments
7.5 NorthEast BioLab
7.5.1 NorthEast BioLab Company Summary
7.5.2 NorthEast BioLab Business Overview
7.5.3 NorthEast BioLab Pharmacokinetics Testing Service Major Product Offerings
7.5.4 NorthEast BioLab Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.5.5 NorthEast BioLab Key News & Latest Developments
7.6 BioAgilytix
7.6.1 BioAgilytix Company Summary
7.6.2 BioAgilytix Business Overview
7.6.3 BioAgilytix Pharmacokinetics Testing Service Major Product Offerings
7.6.4 BioAgilytix Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.6.5 BioAgilytix Key News & Latest Developments
7.7 Washington Biotechnology, Inc.（WBI）
7.7.1 Washington Biotechnology, Inc.（WBI） Company Summary
7.7.2 Washington Biotechnology, Inc.（WBI） Business Overview
7.7.3 Washington Biotechnology, Inc.（WBI） Pharmacokinetics Testing Service Major Product Offerings
7.7.4 Washington Biotechnology, Inc.（WBI） Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.7.5 Washington Biotechnology, Inc.（WBI） Key News & Latest Developments
7.8 Eurofins BioPharma
7.8.1 Eurofins BioPharma Company Summary
7.8.2 Eurofins BioPharma Business Overview
7.8.3 Eurofins BioPharma Pharmacokinetics Testing Service Major Product Offerings
7.8.4 Eurofins BioPharma Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.8.5 Eurofins BioPharma Key News & Latest Developments
7.9 Charles River
7.9.1 Charles River Company Summary
7.9.2 Charles River Business Overview
7.9.3 Charles River Pharmacokinetics Testing Service Major Product Offerings
7.9.4 Charles River Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.9.5 Charles River Key News & Latest Developments
7.10 SCAS
7.10.1 SCAS Company Summary
7.10.2 SCAS Business Overview
7.10.3 SCAS Pharmacokinetics Testing Service Major Product Offerings
7.10.4 SCAS Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.10.5 SCAS Key News & Latest Developments
7.11 Chimera
7.11.1 Chimera Company Summary
7.11.2 Chimera Business Overview
7.11.3 Chimera Pharmacokinetics Testing Service Major Product Offerings
7.11.4 Chimera Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.11.5 Chimera Key News & Latest Developments
7.12 Phoenix WinNonlin
7.12.1 Phoenix WinNonlin Company Summary
7.12.2 Phoenix WinNonlin Business Overview
7.12.3 Phoenix WinNonlin Pharmacokinetics Testing Service Major Product Offerings
7.12.4 Phoenix WinNonlin Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.12.5 Phoenix WinNonlin Key News & Latest Developments
7.13 CD bioparticles
7.13.1 CD bioparticles Company Summary
7.13.2 CD bioparticles Business Overview
7.13.3 CD bioparticles Pharmacokinetics Testing Service Major Product Offerings
7.13.4 CD bioparticles Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.13.5 CD bioparticles Key News & Latest Developments
7.14 ACM Global Laboratories
7.14.1 ACM Global Laboratories Company Summary
7.14.2 ACM Global Laboratories Business Overview
7.14.3 ACM Global Laboratories Pharmacokinetics Testing Service Major Product Offerings
7.14.4 ACM Global Laboratories Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.14.5 ACM Global Laboratories Key News & Latest Developments
7.15 WuXi AppTec
7.15.1 WuXi AppTec Company Summary
7.15.2 WuXi AppTec Business Overview
7.15.3 WuXi AppTec Pharmacokinetics Testing Service Major Product Offerings
7.15.4 WuXi AppTec Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.15.5 WuXi AppTec Key News & Latest Developments
7.16 BioGenes
7.16.1 BioGenes Company Summary
7.16.2 BioGenes Business Overview
7.16.3 BioGenes Pharmacokinetics Testing Service Major Product Offerings
7.16.4 BioGenes Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.16.5 BioGenes Key News & Latest Developments
7.17 Pacific BioLabs
7.17.1 Pacific BioLabs Company Summary
7.17.2 Pacific BioLabs Business Overview
7.17.3 Pacific BioLabs Pharmacokinetics Testing Service Major Product Offerings
7.17.4 Pacific BioLabs Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.17.5 Pacific BioLabs Key News & Latest Developments
7.18 XenoTech
7.18.1 XenoTech Company Summary
7.18.2 XenoTech Business Overview
7.18.3 XenoTech Pharmacokinetics Testing Service Major Product Offerings
7.18.4 XenoTech Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.18.5 XenoTech Key News & Latest Developments
7.19 Medpace
7.19.1 Medpace Company Summary
7.19.2 Medpace Business Overview
7.19.3 Medpace Pharmacokinetics Testing Service Major Product Offerings
7.19.4 Medpace Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.19.5 Medpace Key News & Latest Developments
7.20 SGS
7.20.1 SGS Company Summary
7.20.2 SGS Business Overview
7.20.3 SGS Pharmacokinetics Testing Service Major Product Offerings
7.20.4 SGS Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.20.5 SGS Key News & Latest Developments
7.21 CellCarta
7.21.1 CellCarta Company Summary
7.21.2 CellCarta Business Overview
7.21.3 CellCarta Pharmacokinetics Testing Service Major Product Offerings
7.21.4 CellCarta Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.21.5 CellCarta Key News & Latest Developments
7.22 Precision
7.22.1 Precision Company Summary
7.22.2 Precision Business Overview
7.22.3 Precision Pharmacokinetics Testing Service Major Product Offerings
7.22.4 Precision Pharmacokinetics Testing Service Revenue in Global Market (2018-2023)
7.22.5 Precision Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
